; CX3CR1-GFP + ) mice in the experimental autoimmune encephalomyelitis (EAE) mouse model of MS. Inflammatory lesions were filled with both MDMs and MiDMs. Confocal immunohistochemistry, serial block-face scanning electron microscopy (SBF-SEM), and subsequent 3D reconstruction revealed that myelin destruction was initiated by MDMs, often at the nodes of Ranvier, whereas MiDMs were not detected at this site. Disruption of MDM infiltration by CCR2 deficiency completely abolished the presence of macrophages at the nodes of Ranvier. Gene expression profiling of both cell types at disease onset revealed substantial differences, which correlated well with the observations obtained by SBF-SEM. MDMs expressed genes attributable to effector functions, including those involved in phagocytosis and cell clearance. In contrast, MiMD gene expression patterns at disease onset were characteristic of a repressed metabolic state. This paper sets a new standard for further studies in the field. For the first time, MDMs and MiDMs have been clearly differentiated and their morphological relationship to axoglial structures has been analyzed. The finding that MDMs rather than MiDMs initiate myelin destruction at disease onset should enable this cell population to be targeted more effectively in future. The next stage is to verify these findings in human tissue. Future research should also assess further time points over the entire disease course, in particular to exclude that MiDMs do not join MDMs at the node of Ranvier at later stages of disease. A precise distinction between local and infiltrating cell populations may also contribute to a better understanding of pathogenesis in other CNS disorders such as stroke and brain trauma and will hopefully lead to the development of new therapeutic strategies. Yamasaki, R., et al. 2014 . J. Exp. Med. http://dx.doi.org/10.1084 . Michael T. Heneka, University of Bonn: michael.heneka@ukb.uni-bonn.de < I D > j e m . 2 1 1 8 i n s i g h t 2 f i g 1 . j p e g < / I D > A key challenge at the intestinal barrier is to minimize responses to commensal bacteria, which can lead to inflammatory bowel disease (IBD) in genetically predisposed individuals, but retain the ability to recognize and control the growth of infectious pathogens. Group 3 innate lymphoid cells (ILC3) help maintain intestinal homeostasis by producing the cytokine IL-22, which promotes mucosal healing and maintains barrier integrity. Microbial signals trigger production of IL-23 and IL-1␤, which stimulate ILC3s to produce IL-22, leading to the induction of antibacterial peptides and epithelial cell regeneration.
But the identity of the cell type producing IL-23 in response to microbial signals is unclear and has been the subject of much debate; resident mononuclear phagocytes, inflammatory monocytes, and conventional dendritic cells have all been implicated. In this issue, Longman et al. provide compelling evidence, both in mouse following Citrobacter rodentium infection and in patients with colitis, that CX 3 CR1 + mononuclear phagocytes (MNPs) are the most potent producers of IL-23 and IL-1␤ and are very efficient in inducing IL-22 production by ILC3. 
i n s i g h t 2 < / a i d > < a u > G i o r g i o T r i n c h i e r i < / a u > < A F 1 > N a t i o n a l C a n c e r I n s t i t u t e , N a t i o n a l I n s t i t u t e s o f H e a l t h < / A F 1 > < c o r > t r i n c h i g @ m a i l . n i h . g o v < / c o r > < d o c h e a d > I n s i g h t s < / d o c h e a d > < d o c t o p i c > N e w s < / d o c t o p i c > Cr itical role for CX 3 CR1 + mononuclear phagocytes in intestinal homeostasis
Insight from Giorgio Trinchieri < I D > j e m . 2 1 1 8 i n s i g h t 2 f i g 2 . e p s < / I D > The authors demonstrated the importance of microbial stimulation in IL-22 induction in patients with surgical diversion of the fecal stream-IL-22 production by ILC3 was lower in the sites unexposed to the gut microbiota compared with exposed sites. Microbial TLR4 and TLR9 agonists were particularly efficient at inducing IL-23 and IL-1␤ production by CX 3 CR1 + MNPs. The authors also discovered that a gene significantly associated with both ulcerative colitis and Crohn's disease in GWAS, TNF-like ligand 1A (TL1A or TNFSF15), is overexpressed in mouse CX 3 CR1 + MNPs and synergizes with IL-23 and IL-1␤ to induce IL-22 production in both human and mouse ILC3.
The study does not completely exclude the role of other cell types in the production of IL-23 and induction of IL-22 production but in the conditions studied (mouse infection with C. rodentium and human colitis), CX 3 CR1 + MNPs were crucial in mediating this mucosal protective loop. In basal conditions or in other types of inflammatory or preneoplastic conditions, and under stimulation by different microbial TLR agonists (e.g., flagellin), it is quite possible that other cell types, including conventional dendritic cells, may play an important role, as suggested by published studies. However, the study by Longman et al. greatly contributes to our understanding of the mechanisms of human IBD and reassures us that when mouse data are carefully combined with experimental human studies and GWAS, they are powerful in providing mechanistic evidence that explains human pathology. including a general preservation of TCR docking mode on the MR1, conserved interaction of a key TCR ␣-chain CDR3-encoded residue (Tyr95α) with the antigen, and significant interactions of the hypervariable CDR3␤ loop with the antigen. The characterization of a strong antagonist of MAIT TCR recognition reveals plasticity of the MR1 binding pocket to accommodate the ligand and shows how the ligand itself can affect MR1 stability.
Collectively, these structures indicate that although the conserved TCR V␣-chain plays a major role in MR1 interaction, it also contributes to recognition of stimulatory antigens, whereas V␤ differences may accommodate subtle differences among distinct antigens. These studies support the view that MAIT cells co-evolved with their MR1-presenting element to recognize metabolic products from distinct intracellular microorganisms, conserving the V␣ and J␣ much like innate pattern recognition receptors, but allowing the V␤-chains to vary according to the particular pathogen, following the scheme of adaptive immunity.
So, MAIT cells seem to be an "in-between" type of T cell with semi-invariant TCRs, recognizing antigens (at least those we now know) derived from metabolic products of lower organisms, and utilizing conserved, invariant presentation molecules. However, the questions that remain are provocative. How varied are the MR1-presented antigens? How do the metabolitederived antigens load onto MR1 molecules, and how do they cross organelle barriers from the intracellular sites of infection? Are there self-antigens that mimic the vitamin metabolites for MR1 binding and MAIT cell selection? Can we find ancestral invariant TCR-like molecules that bind MR1-like predecessors that still respond to metabolite antigens?
Although many questions remain, these papers not only enhance our understanding of the evolution and function of MAIT cells and their novel TCRs, but also provide a new perspective on the many immunological solutions that nature has developed to combat pathogens. 
